If you have been reading about MC1R and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms add to total mass |
| Molecular mass | About 1024 daltons | Calculated for the free base |
| Structural class | Cyclic heptapeptide | Contains D-phenylalanine and norleucine |
| Parent hormone | Alpha-melanocyte-stimulating hormone | Endogenous tridecapeptide of 13 residues |
| Receptor profile | Non-selective melanocortin agonist | Interacts with MC1R, MC3R, MC4R and MC5R |
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
1,3-Beta-glucan synthase is a glucosyltransferase enzyme involved in the generation of beta-glucan in fungi. It serves as a pharmacological target for antifungal drugs such as caspofungin, anidulafungin, and micafungin, deemed 1,3-Beta-glucan synthase inhibitors. Under the CAZy classification system, fungi and plant members fall in the glycosyltransferase 48 family (GT48). Some members of the glycosyltransferase 2 family (Pfam PF13632), such as the curdlan synthase CrdS (Q9X2V0), also has a similar activity. The biosynthesis of disaccharides, oligosaccharides, and polysaccharides involves the action of hundreds of different glycosyltransferases. These enzymes catalyse the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. The family consists of various 1,3-beta-glucan synthase components including Gls1, Gls2, and Gls3 from yeast. 1,3-Beta-glucan synthase (EC 2.4.1.34.) also known as callose synthase catalyses the formation of a beta-1,3-glucan polymer that is a major component of the fungal cell wall. The reaction catalysed is:
The strontium radioisotopes are very important, as strontium is a calcium mimic which is incorporated in bone growth and therefore has a great ability to harm humans. On the other hand, this also allows 89Sr to be used in the open source radiotherapy of bone tumors. This tends to be used in palliative care to reduce the pain due to secondary tumors in the bones. Strontium-90 is a strong beta emitter with a half-life of 28.8 years. Its fission product yield decreases as the mass of the fissile nuclide increases - fission of 233U produces more 90Sr than fission of 239Pu with fission of 235U in the middle. A map of 90Sr contamination around Chernobyl has been published by the IAEA. Due to its very small neutron absorption cross section, strontium-90 is poorly suited for thermal neutron induced nuclear transmutation as a way of disposing of it. Strontium-90 has been used in radioisotope thermoelectric generators (RTGs) in the past because of its relatively high power density (0.95 Wthermal/g for the metal, 0.46 Wthermal/g for the commonly used inert perovskite form strontium titanate) and because it is easily extracted from spent fuel (both native strontium metal and strontium oxide react with water by forming soluble strontium hydroxide). However, the increased availability of renewable energy for off-grid applications formerly served by RTGs as well as concern about orphan sources has led to a nigh-total abandonment of 90Sr in RTGs.
== George H.W. Bush administration == In August 1989, during his first year in office, President George H. W. Bush announced that drugs were "the most pressing issue facing our nation." During the speech, Bush held up a bag of crack into the camera as he blamed "everyone using drugs" to be "the greatest threat to America." A New York Times/CBS News poll that year reported that 64% of those polled, the highest ever recorded, saw drugs as the most dangerous issue facing the nation. As recently as 1982, a poll on a similar issue recorded that just 2% of the nation saw drugs as the most pressing issue. Some scholars attribute the rise in public sentiment to an increase in drug activity. That opinion has been criticized, however, by those believe that the surge of public concern is more closely connected to a dramatic shift in political campaigns, public initiatives, and partisan appeals.
Sources: en.wikipedia.org
An N-terminal KOW-like domain A central OB domain, which forms an oligonucleotide-binding (OB)-fold. It is not clear if this region is involved in binding nucleic acids A C-terminal domain which adopts an OB-fold, with five beta-strands forming a beta-barrel in a Greek-key topology Eukaryotes and archaea lack EF-P. In these domains, a similar function is performed by the archaeo-eukaryotic initiation factor, a/eIF-5A, which exhibits some modest sequence and structural similarity with EF-P. There are, however, important differences between EF-p and eIF-5A. (a) EF-P has a structure similar to that of L-shaped tRNA and it contains three (I, II and III) β-barrel domains. In contrast, eIF-5A contains only two domains (C and N) with a corresponding size difference. (b) Moreover, as opposed to eIF-5A, which contains the non-proteinogenic amino acid hypusine that is essential for its activity, EF-P displays a diversity of post-transcriptional modifications at the analogous position (β-lysylation of lysine residue, rhamnosylation of arginine residue, or none at all).
== See also == Analytical chemistry Chromatography Gas chromatography–mass spectrometry Gas chromatography-olfactometry High-performance liquid chromatography Inverse gas chromatography Proton transfer reaction mass spectrometry Secondary electrospray ionization Selected ion flow tube mass spectrometry Standard addition Thin layer chromatography Unresolved complex mixture
Mummies from Oceania are not limited only to Australia. Discoveries of mummified remains have also been located in New Guinea, New Zealand, and the Torres Strait, though these mummies have been historically harder to examine and classify. Prior to the 20th century, most literature on mummification in the region was either silent or anecdotal. However, the boom of interest generated by the scientific study of Egyptian mummification lead to more concentrated study of mummies in other cultures, including those of Oceania.
Sources: en.wikipedia.org
Political developments in the Soviet Union included Stalin dismantling the remaining elements of democracy from the party by extending his control over its institutions and eliminating any possible rivals. The party's ranks grew in numbers, with the party modifying its organisation to include more trade unions and factories. The ranks and files of the party were populated with members from the trade unions and the factories, whom Stalin controlled because there were no other Old Bolsheviks to contradict Marxism–Leninism. In the late 1930s, the Soviet Union adopted the 1936 Soviet Constitution which ended weighted-voting preferences for workers, promulgated universal suffrage for every man and woman older than 18 years of age and organised the soviets (councils of workers) into two legislatures, namely the Soviet of the Union (representing electoral districts) and the Soviet of Nationalities (representing the ethnic groups of the country). By 1939, with the exception of Stalin himself, none of the original Bolsheviks of the October Revolution of 1917 remained in the party. Unquestioning loyalty to Stalin was expected by the regime of all citizens. Stalin exercised extensive personal control over the party and unleashed an unprecedented level of violence to eliminate any potential threat to his regime. While Stalin exercised major control over political initiatives, their implementation was in the control of localities, often with local leaders interpreting the policies in a way that served themselves best.
Kyle Hardingham (born 1 September 1988) is a former professional Australian rules footballer who played for the Essendon Football Club in the Australian Football League (AFL). Hardingham was selected by Essendon with the seventh pick in the 2010 AFL Pre-Season Draft. Originally from East Fremantle in the WAFL, he represented Western Australia in the state game against South Australia in 2009. He made his AFL debut against North Melbourne in round 17 of the 2010 AFL season, kicking four goals, helping Essendon achieve an upset victory by 3 points. The following Friday night, he kicked two goals in a win against St Kilda. He managed to kick two goals once again in the next game, a 76-point loss to Carlton, although he also kicked two behinds as part of the wayward kicking by the entire Essendon team, which managed 9.19 for the night. Hardingham was delisted at the conclusion of the 2014 AFL season. He remained with Essendon as a VFL-listed player in its reserves team in 2016. Hardingham, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his teammates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, but a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency. He was suspended for two years which, with backdating, ended in November 2016; as a result, he served approximately fourteen months of his suspension and missed the entire 2016 season.
=== Oxazolidines === Oxazolidines are a five-membered ring compounds consisting of three carbons, a nitrogen, and an oxygen. The oxygen and NH are the 1 and 3 positions, respectively. In oxazolidine derivatives, there is always a carbon between the oxygen and the nitrogen.
Sources: en.wikipedia.org
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.
Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.
Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.